HealthcareServices

Malaria Vaccines Market Growth Projection: Expected to Surpass $27.18 Billion by 2030 at 34.3% CAGR

February 26, 2026February 26, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the malaria vaccines market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Malaria Vaccines Market be in 2030 compared with 2026?

The market size for malaria vaccines has witnessed substantial growth in recent years. This market is anticipated to expand from $6.24 billion in 2025 to $8.36 billion in 2026, at a compound annual growth rate (CAGR) of 33.9%. This past expansion can be linked to factors such as the significant malaria burden in endemic regions, ongoing global malaria eradication initiatives, financial support from international health organizations, the challenges presented by antimalarial drug resistance, and the initial achievements of first-generation malaria vaccines.

The malaria vaccines market is projected to experience rapid expansion over the coming years. This market is anticipated to reach a valuation of $27.18 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 34.3%. Factors contributing to this growth during the forecast period include enhanced government investment in preventing infectious diseases, the increasing geographical spread of malaria-susceptible areas due to climate change, a heightened need for vaccines providing extended immunity, progress in vaccine research and clinical trials, and broader immunization access in lower-income nations. Key trends for the forecast period encompass the development of advanced next-generation malaria vaccines, a heightened emphasis on immunization initiatives for children, a rise in collaborations between public and private sectors for vaccine distribution, an increased focus on vaccines targeting multiple antigens and combination formulations, and the reinforcement of large-scale vaccination efforts in areas where the disease is prevalent.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13698&type=smp

What Drivers Are Guiding Growth Patterns In The Malaria Vaccines Market?

The increasing prevalence of mosquito-related diseases is projected to propel the growth of the malaria vaccine market in the coming years. These diseases encompass a wide range of illnesses transmitted through the bite of an infected mosquito. The malaria vaccine, particularly the RTS, S/AS01 (RTS, S) vaccine, is utilized to prevent and reduce the impact of mosquito-borne infectious diseases by training the immune system to recognize and attack the parasite. For instance, in December 2024, the UK Health Security Agency (UKHSA), a UK-based government department, released its annual malaria report for 2023, which indicated 2,106 cases of imported malaria reported in the UK. This represents a 26% higher figure than the cases reported in 2022. Therefore, the rise in the incidence of mosquito-related diseases is driving the growth of the malaria vaccine market.

Which Segments Are Driving Activity In The Malaria Vaccines Market?

The malaria vaccines market covered in this report is segmented –

1) By Agent: Plasmodium Falciparum, Plasmodium Vivax

2) By Vaccine Type: Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines

3) By Route Of Administration: Intramuscular, Subcutaneous, Intradermal, Other Routes Of Administration

4) By Distribution Channel: Public, Private

Subsegments:

1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine, Experimental Vaccines

2) By Plasmodium Vivax: Candidate Vaccines In Development, Combination Vaccines

Which Market Trends Are Opening Growth Opportunities In The Malaria Vaccines Market?

Major companies in the malaria vaccines market are concentrating on developing innovative solutions, such as next-generation recombinant vaccines, to meet the increasing demand fueled by rising malaria prevalence, government backing, and expanding immunization programs. These next-generation recombinant vaccines utilize sophisticated genetic engineering techniques to target various stages of the malaria parasite’s life cycle, providing enhanced immune responses and more sustained protection compared to conventional vaccines that often target a single stage with limited effectiveness. For instance, in October 2025, the Government of the Republic of Zambia introduced the malaria vaccine R21/Matrix-M as a component of its Expanded Programme on Immunisation. This vaccine, a collaborative effort by the University of Oxford and the Serum Institute of India, employs a recombinant protein platform in conjunction with the Matrix-M adjuvant to augment immune response, is administered through a four-dose schedule commencing at 6 months of age, and is designed to complement existing anti-malaria interventions. The vaccine delivers higher efficacy rates and aims to protect children in high and moderate transmission districts across Zambia, substantially aiding malaria elimination endeavors.

Which Major Industry Participants Are Leading The Malaria Vaccines Market Growth?

Major companies operating in the malaria vaccines market are GlaxoSmithKline Plc, Bharat Biotech International Limited, Serum Institute of India Private Limited, Sanaria Inc, BioNTech SE, Moderna Inc, Pfizer Inc, Novavax Inc, Takeda Pharmaceutical Company Limited, Sanofi SA, Zydus Lifesciences Limited, Valneva SE, GeoVax Labs Inc, Inovio Pharmaceuticals Inc, Vaxart Inc, CanSino Biologics Inc, Sinovac Biotech Ltd, Clover Biopharmaceuticals Inc, Biological E Limited, Emergent BioSolutions Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Malaria Vaccines Market?

North America was the largest region in the malaria vaccines market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the malaria vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Malaria Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13698&type=smp

Browse Through More Reports Similar to the Global Malaria Vaccines Market 2026, By The Business Research Company

Therapeutic Bcg Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Malaria Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795